[BAT] YoY Quarter Result on 31-Mar-2015 [#1]

Stock
[BAT] BRITISH AMERICAN TOBACCO (M)
Announcement Date
28-Apr-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 30.3%
YoY- 7.25%
Quarter Report
Latest QR
Upcoming QR
BAT's Result
BAT's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 637,649 748,374 1,021,012 1,274,071 1,154,310 1,095,739 1,042,762 -7.86%
PBT 126,626 156,384 231,073 324,681 301,186 273,997 261,562 -11.38%
Tax -30,400 -37,591 -55,599 -81,326 -75,792 -69,793 -67,053 -12.34%
NP 96,226 118,793 175,474 243,355 225,394 204,204 194,509 -11.06%
-
NP to SH 95,884 114,233 172,606 241,742 225,394 204,204 194,509 -11.11%
-
Tax Rate 24.01% 24.04% 24.06% 25.05% 25.16% 25.47% 25.64% -
Total Cost 541,423 629,581 845,538 1,030,716 928,916 891,535 848,253 -7.20%
-
Net Worth 354,057 376,899 496,822 579,625 511,098 468,269 439,858 -3.55%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Div 94,224 114,212 157,041 222,713 214,147 194,160 185,654 -10.68%
Div Payout % 98.27% 99.98% 90.98% 92.13% 95.01% 95.08% 95.45% -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Net Worth 354,057 376,899 496,822 579,625 511,098 468,269 439,858 -3.55%
NOSH 285,530 285,530 285,530 285,530 285,530 285,530 285,622 -0.00%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 15.09% 15.87% 17.19% 19.10% 19.53% 18.64% 18.65% -
ROE 27.08% 30.31% 34.74% 41.71% 44.10% 43.61% 44.22% -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 223.32 262.10 357.58 446.21 404.27 383.76 365.08 -7.86%
EPS 33.70 41.60 61.50 85.20 78.90 71.50 68.10 -11.05%
DPS 33.00 40.00 55.00 78.00 75.00 68.00 65.00 -10.67%
NAPS 1.24 1.32 1.74 2.03 1.79 1.64 1.54 -3.54%
Adjusted Per Share Value based on latest NOSH - 285,530
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 223.32 262.10 357.58 446.21 404.27 383.76 365.20 -7.86%
EPS 33.70 41.60 61.50 85.20 78.90 71.50 68.12 -11.06%
DPS 33.00 40.00 55.00 78.00 75.00 68.00 65.02 -10.68%
NAPS 1.24 1.32 1.74 2.03 1.79 1.64 1.5405 -3.55%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 -
Price 26.42 45.60 54.04 68.66 59.12 62.16 56.62 -
P/RPS 11.83 17.40 15.11 15.39 14.62 16.20 15.51 -4.41%
P/EPS 78.68 113.98 89.39 81.10 74.89 86.92 83.14 -0.91%
EY 1.27 0.88 1.12 1.23 1.34 1.15 1.20 0.94%
DY 1.25 0.88 1.02 1.14 1.27 1.09 1.15 1.39%
P/NAPS 21.31 34.55 31.06 33.82 33.03 37.90 36.77 -8.68%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 21/05/18 20/04/17 26/04/16 28/04/15 24/04/14 23/04/13 23/04/12 -
Price 33.40 47.06 54.50 65.94 61.60 62.46 55.50 -
P/RPS 14.96 17.95 15.24 14.78 15.24 16.28 15.20 -0.26%
P/EPS 99.46 117.63 90.16 77.88 78.04 87.34 81.50 3.37%
EY 1.01 0.85 1.11 1.28 1.28 1.15 1.23 -3.22%
DY 0.99 0.85 1.01 1.18 1.22 1.09 1.17 -2.74%
P/NAPS 26.94 35.65 31.32 32.48 34.41 38.09 36.04 -4.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment